A prospective, phase IV study of ixazomib, pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

Runfeng Zhang, Hong Yu, Miao Chen, Xiaoqi Qin, Jie Xiao, Yun Leng, Mingzhe Zhao, Jie Yu, Chunjie Qin, Xiuju Wang, Jingcheng Zhang, Wei Wang, Wenming Chen, Yanping Ma, Rong Fu, Junling Zhuang
British Journal of Haematology · Wiley · 2026-11-10 · DOI: 10.1111/bjh.70806

Аннотация

British Journal of Haematology, Volume 209, Issue 5, Page 2316-2320, November 2026.

Читать у издателя →

Похожие статьи